India tackles rare diseases head-on at landmark summit in New Delhi
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
India’s pharmaceutical sector stands at a pivotal inflection point
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
The plant is expected to enhance regional supply capabilities
Subscribe To Our Newsletter & Stay Updated